These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy. Zhang X; Zhang G; Zhao Z; Xiu R; Jia J; Chen P; Liu Y; Wang Y; Yi J Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119132. PubMed ID: 34450215 [TBL] [Abstract][Full Text] [Related]
23. Ani9, A Novel Potent Small-Molecule ANO1 Inhibitor with Negligible Effect on ANO2. Seo Y; Lee HK; Park J; Jeon DK; Jo S; Jo M; Namkung W PLoS One; 2016; 11(5):e0155771. PubMed ID: 27219012 [TBL] [Abstract][Full Text] [Related]
24. The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling. Bill A; Alex Gaither L Adv Exp Med Biol; 2017; 966():1-14. PubMed ID: 28293832 [TBL] [Abstract][Full Text] [Related]
25. SMYD3 regulates the abnormal proliferation of non-small-cell lung cancer cells via the H3K4me3/ANO1 axis. Zhong D; Zhan Z; Zhang J; Liu Y; He Z J Biosci; 2022; 47():. PubMed ID: 36222132 [TBL] [Abstract][Full Text] [Related]
26. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153 [TBL] [Abstract][Full Text] [Related]
27. Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics. Bill A; Hall ML; Borawski J; Hodgson C; Jenkins J; Piechon P; Popa O; Rothwell C; Tranter P; Tria S; Wagner T; Whitehead L; Gaither LA J Biol Chem; 2014 Apr; 289(16):11029-11041. PubMed ID: 24599954 [TBL] [Abstract][Full Text] [Related]
28. Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery. He Y; Li H; Chen Y; Li P; Gao L; Zheng Y; Sun Y; Chen J; Qian X Clin Transl Oncol; 2017 Sep; 19(9):1091-1098. PubMed ID: 28299581 [TBL] [Abstract][Full Text] [Related]
29. ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers. Park S; Das R; Nhiem NX; Jeong SB; Kim M; Kim D; Oh HI; Cho SH; Kwon OB; Choi JH; Park CS; Kim SR; Moon UY; Cha B; Choi DK; Lee S; Namkung W; Woo J; Seo Y Front Pharmacol; 2023; 14():1163970. PubMed ID: 37274097 [TBL] [Abstract][Full Text] [Related]
30. The Ca Liu Y; Liu Z; Wang K Acta Pharm Sin B; 2021 Jun; 11(6):1412-1433. PubMed ID: 34221860 [TBL] [Abstract][Full Text] [Related]
31. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553 [TBL] [Abstract][Full Text] [Related]
32. Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression. Sim KM; Lee YS; Kim HJ; Cho CH; Yi GS; Park MJ; Hwang EM; Park JY Cells; 2020 Apr; 9(5):. PubMed ID: 32357567 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway. Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053 [TBL] [Abstract][Full Text] [Related]
34. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819 [TBL] [Abstract][Full Text] [Related]
35. TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer. Hu C; Zhang R; Jiang D Arch Iran Med; 2019 Jan; 22(1):32-38. PubMed ID: 30821158 [TBL] [Abstract][Full Text] [Related]
36. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells. Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757 [TBL] [Abstract][Full Text] [Related]
37. The role of anoctamin 1 in liver disease. Li X; Wang Y; Zhang L; Yao S; Liu Q; Jin H; Tuo B J Cell Mol Med; 2024 May; 28(9):e18320. PubMed ID: 38685684 [TBL] [Abstract][Full Text] [Related]
38. Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells. Lee YS; Lee JK; Bae Y; Lee BS; Kim E; Cho CH; Ryoo K; Yoo J; Kim CH; Yi GS; Lee SG; Lee CJ; Kang SS; Hwang EM; Park JY Sci Rep; 2016 May; 6():26413. PubMed ID: 27212225 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Liu W; Lu M; Liu B; Huang Y; Wang K Cancer Lett; 2012 Dec; 326(1):41-51. PubMed ID: 22820160 [TBL] [Abstract][Full Text] [Related]
40. Role of ANO1 in tumors and tumor immunity. Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]